Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: Relation to prognosis

British Journal of Cancer

Volumn 90, Issue 10, 2004, Pages 1961-1968

  Strojan, P ^a   Oblak, I ^a   Svetic, B ^a   Smid L ^b   Kos, J ^c,d  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d KRKA   (Slovenia)

Author keywords

Cystatin C; Head and neck cancer; Prognosis; Squamous cell carcinoma

Indexed keywords

CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR; STEFIN A; CYSTATIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEAD CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SQUAMOUS CELL CARCINOMA; COHORT ANALYSIS; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CEREBROSPINAL FLUID PROTEINS; COHORT STUDIES; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 2942566514     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601830     Document Type: Article

References (49)

1. Abel U, Berger J, Wiebelt H (1984) Critlevel: an exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inform Med 23: 154-156
2. Abrahamson M, Mason RW, Hansson H, Buttle DJ, Grubb A, Ohlsson K (1991) Human cystatin C: role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J 273: 621-626
3. Azzopardi JG, Chepizk OF, Hartman WH (1981) International Histological Classification of Tumours No 2: Histological Typing of Breast Tumours. Geneva: World Health Organization
4. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
5. Chapman HA, Riese RJ, Shi GP (1997) Emerging roles for cysteine proteinases in human biology. Annu Rev Physiol 59: 63-88
6. Cimerman N, Trstenjak Prebanda M, Turk B, Popovič T, Dolenc I, Turk V (1999) Interaction of cystatin C variants with papain and human cathepsins B, H and L. J Enzyme Inhibition 14: 167-174
7. Corticchiato O, Cajot JF, Abrahamson M, Chan SJ, Keppler D (1992) Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation. Int J Cancer 52: 645-652
8. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Glössl J, Mach L (1999) Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 83: 526-531
9. Cox DR (1972) Regression models and life tables. J Roy Stat Soc 187: 187-220
10. Cox JL, Sexton PS, Green TJ, Darmani NA (1999) Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res 9: 369-374
11. Ebert E, Werle B, Jülke B, Kopitar-Jerala N, Kos J, Lah T, Abrahamson M, Spiess E, Ebert W (1997) Expression of cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue. Adv Exp Med Biol 421: 259-265
12. Ekiel I, Abrahamson M (1996) Folding-related dimerization of human cystatin C. J Biol Chem 271: 1314-1321
13. Foekens JA, Kos J, Peters HA, Krašovec M, Look MP, Cimerman N, Meijervan Gelder ME, Henzen-Logmans SC, van Putten WLJ, Klijn JGM (1998) Prognostic significance of cathepsins B and L in primary human breast cancer. J Clin Oncol 16: 1013-1021
14. Gaumann A, Hansen T, Köhler HH, Kommoss F, Mann W, Maurer J, Kirkpatrick CJ, Kriegsmann J (2001) The expression of cathepsins in osteoclast-like giant cells of an anaplastic thyroid carcinoma with tracheal perforation. Pathol Res Pract 197: 257-262
15. Hansen T, Petrow PK, Gaumann A, Keyszer GM, Otto M, Kirkpatrick CJ, Kriegsmann J (2001) Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath. Mod Pathol 14: 318-324
16. Hirai K, Yokoyama M, Asano G, Tanaka S (1999) Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol 30: 680-686
17. Huh CG, Håkansson K, Nathanson CM, Thorgeirsson UP, Jonsson N, Grubb A, Abrahamson M, Karlsson S (1999) Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. J Clin Pathol: Mol Pathol 52: 332-340
18. Jaattela M (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res 248: 30-43
19. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481
20. Knoch H, Werle B, Ebert W, Spiess E (1994) Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int J Oncol 5: 77-85
21. Konduri SD, Yanamandra N, Siddique K, Joseph A, Dinh DH, Olivero WC, Gujrati M, Kouraklis G, Swaroop A, Kyritsis AP, Rao JS (2002) Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 21: 8705-8712
22. Kos J, Krašovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brünner N (2000a) Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res 6: 505-511
23. Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 5: 1349-1361
24. Kos J, Werle B, Lah T, Brunner N (2000b) Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 15: 84-89
25. Kothapalli R, Bailey RD, Kusmartseva I, Mane S, Epling-Burnette PK, Loughran TS (2003) Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 22: 33-39
26. Křepela E, Procházka J, Kárová B, Čermák J, Roubková H (1998) Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma 45: 318-331
27. Křepela E, Procházka J, Mynaříková H, Kárová B, Polák J, Čermák J, Roubková H (1995) Multiple forms of cathepsin B in human lung cancer. Int J Cancer 61: 44-53
28. Lah TT, Clifford JL, Helmer KM, Day NA, Moin K, Honn KV, Crissman JD, Sloane BF (1989) Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim Biophys Acta 993: 63-73
29. Lah TT, Kokalj-Kunovar M, Štrukelj B, Pungerčar J, Barlič-Magajna D, Drobnič-Košorok M, Kastelic L, Babnik J, Golouh R, Turk V (1992) Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer 50: 36-44
30. Lah TT, Kos J, Blejec A, Frkovič-Georgio S, Golouh R, Vrhovec I, Turk V (1997) The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease. Pathol Oncol Res 3: 89-99
31. Lal H (1994) Biochemical studies in head and neck cancers. Clin Biochem 27: 235-295
32. Lenarčič B, Krašovec M, Ritonja A, Olafsson I, Turk V (1991) Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett 280: 211-215
33. Lignelid H, Collins VP, Jacobsson B (1997) Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol 93: 494-500
34. Lignelid H, Jacobsson B (1992) Cystatin C in the human pancreas and gut: an immunohistochemical study of normal and neoplastic tissues. Wirchows Archiv Pathol Anat 421: 491-495
35. Look MP, van Putten WLJ, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Sweep CGJF, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LVAM, Klijn JGM, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens JA (2002) Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94: 116-128
36. Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI, Wisniewski HM (1997) Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 173: 423-432
37. Newman DJ (2002) Cystatin C. Ann Clin Biochem 39: 89-104
38. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patients. II. Analysis and examples. Br J Cancer 35: 1-39
39. Poteryaeva ON, Falameeva OV, Zhanaeva SY, Svechnikova IG, Korolenko TA, Kaledin VI (2001) Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosarcoma. Bull Exp Biol Med 1: 675-677
40. Quon H, Liu FF, Cummings BJ (2001) Potential molecular prognostic markers in head and neck squamous cell carcinoma. Head Neck 23: 147-159
41. Sexton PS, Cox JL (1997) Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C. Melanoma Res 7: 97-101
42. Sloane BF, Moin K, Lah TT (1994) Regulation of lysosomal endopeptidases in malignant neoplasia. In Biochemical and Molecular Aspects of Selected Cancers, Pretlow TG, Pretlow TP (eds). pp 411-472. NewYork: Academic Press
43. Sobin LH, Wittekind Ch (1997) TNM Classification of Malignant Tumours. International Union Against Cancer (UICC). New York: Wiley-Liss
44. Strojan P, Budihna M, Šmid L, Svetec B, Vrhovec I, Kos J, Škrk J (2000) Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 6: 1052-1062
45. Strojnik T, Židanik B, Kos J, Lah TT (2001) Cathepsins B and L are markers in clinically invasive types of meningiomas. Neurosurgery 48: 598-605
46. Szpaderska AM, Frankfater A (2001) An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res 61: 3493-3500
47. Yano M, Hirai K, Naito Z, Yokoyama M, Ishiwata T, Shiraki Y, Inokuchi M, Asano G (2001) Expression of cathepsin B and cystatin C in human breast cancer. Surg Today 31: 385-389
48. Yoshimura K, Tsuchida T, Kawamoto K (2000) Expression of cathepsin B and cystatin C in the human adenohypophysis and in pituitary adenomas. Oncol Rep 7: 27-31
49. Zore I, Krašovec M, Cimerman N, Kuhelj R, Werle B, Nielsen HJ, Brünner N, Kos J (2001) Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem 382: 805-810